# Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid

> **NCT02313870** · PHASE3 · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 322 (actual)

## Conditions studied

- Bullous Pemphigoid

## Interventions

- **DRUG:** clobetasol propionate + Methotrexate
- **DRUG:** clobetasol propionate alone

## Key facts

- **NCT ID:** NCT02313870
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-22
- **Primary completion:** 2015-05-26
- **Final completion:** 2015-12-31
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02313870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02313870, "Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02313870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*